Chairman, Richard Fang Appointed Interim Chief Executive OfficerTUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced a leadership transition. Patrick NJ Schnegelsberg has stepped down as Chief Executive Officer and as a member of